<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2019-23-2-49-76</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1677</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>К ВОПРОСУ О ПЕРСПЕКТИВАХ ОБНОВЛЕНИЯ КЛИНИЧЕСКИХ РЕКОМЕНДАЦИЙ ПО ГЕМОДИАЛИЗУ</article-title><trans-title-group xml:lang="en"><trans-title>TO THE QUESTION ABOUT THE PROSPECTIVE FOR THE UPDATES OF CLINICAL GUIDELINES FOR HEMODIALYSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Румянцев</surname><given-names>А. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Rumyantsev</surname><given-names>A. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Проф., д-р мед наук, Санкт-Петербургский государственный университет, кафедра факультетской терапии</p></bio><bio xml:lang="en"><p>Prof., MD, PhD, DMedSci, Saint Petersburg State University Department of Faculty Therapy</p></bio><email xlink:type="simple">rash.56@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Земченков</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zemchenkov</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ББраун Авиум Руссланд Клиникс</p></bio><bio xml:lang="en"><p>MD, BBraun Avitum Russland Clinics</p></bio><email xlink:type="simple">zga13@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сабодаш</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Sabodash</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доц., канд. мед. наук, Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова, кафедра нефрологии и диализа</p></bio><bio xml:lang="en"><p>Associate professor, MD, PhD, Pavlov First Saint Petersburg State Medical University, Department of Nephrology and dialysis</p></bio><email xlink:type="simple">sabodash@list.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Санкт-Петербургский государственный университет;&#13;
Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint Petersburg State University;&#13;
Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ББраун Авитум Руссланд Клиникс,&#13;
Санкт-Петербург</institution><country>Россия</country></aff><aff xml:lang="en"><institution>BBraun Avitum Russland Clinics;</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ББраун Авитум Руссланд Клиникс,&#13;
Санкт-Петербург;&#13;
Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>BBraun Avitum Russland Clinics;&#13;
Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>20</day><month>02</month><year>2019</year></pub-date><volume>23</volume><issue>2</issue><fpage>49</fpage><lpage>76</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Румянцев А.Ш., Земченков Г.А., Сабодаш А.Б., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Румянцев А.Ш., Земченков Г.А., Сабодаш А.Б.</copyright-holder><copyright-holder xml:lang="en">Rumyantsev A.S., Zemchenkov G.A., Sabodash A.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1677">https://journal.nephrolog.ru/jour/article/view/1677</self-uri><abstract><p>За последние годы получено много новых данных относительно тактики и стратегии диализной терапии, которые требуют пересмотра имеющихся клинических рекомендаций. Данный обзор современных критериев адекватности гемодиализа построен в соответствии с работой групп Согласительной конференции KDIGO 2018 года, являющейся основой разработки обновления будущих клинических рекомендаций Международного общества нефрологов. Следует признать, что интенсификация отдельного сеанса диализа достигла предела в части улучшения значимых исходов. Вместе с тем, индивидуальный выбор модальности диализа, условий старта и подготовки к нему, оптимизация скорости ультрафильтрации, выбор состава диализирующего раствора, использование инструментальных методов в коррекции водного баланса позволяют расширить возможности лечения. Сами результаты лечения следует оценивать с пациент-ориентированных позиций. Понятие «целевая эффективность» для пожилых и ослабленных пациентов должно постепенно уступить место понятию «целевая переносимость», при которой адекватный диализ должен обладать минимальными побочными эффектами. В то же время, более частый высокоэффективный диализ может дать преимущества в группе молодых пациентов с высокими метаболическими потребностями. Стоит обратить внимание на диссонанс между оценкой значимости исходов для пациентов и врачей: взаимное понимание целей и желаний приведет к увеличению податливости лечению и удовлетворенности его результатами. Назначение любого лечения (в том числе, диализа) должно, в первую очередь, не вступать в противоречие с императивом «noli nocere!».</p></abstract><trans-abstract xml:lang="en"><p>In recent years, many new data have been obtained regarding the tactics and strategy of dialysis therapy, which require a revision of existing clinical guidelines. This review of modern criteria for the adequacy of hemodialysis is built in accordance with the Working groups of the 2018 KDIGO Controversies Conference, which is the basis for the development of the update of future clinical guidelines of the International Society of Nephrology. It should be recognized that the intensification of a certain dialysis session has reached a limit in terms of improving meaningful outcomes. At the same time, the individual choice of dialysis modality, conditions for starting and preparing for it, optimization of the ultrafiltration rate, selection of the composition of dialysis solution, and the use of instrumental methods in correcting the water balance allow expanding the possibilities of treatment. The results of the treatment should be evaluated from a patient-oriented position. The concept of “target efficacy” for elderly and frailty patients should gradually give way to the concept of “target tolerance”, in which adequate dialysis should have minimal side effects. At the same time, more frequent, highly effective dialysis may be beneficial in a group of young patients with high metabolic needs. It is worth paying attention to the discord between assessing the significance of outcomes for patients and doctors: a mutual understanding of goals and desires will lead to an increase in compliance with treatment and satisfaction with its results. The purpose of any treatment (including dialysis) should, first of all, not be in conflict with the imperative "noli nocere!".</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гемодиализ</kwd><kwd>адекватность</kwd><kwd>клинические рекомендации</kwd><kwd>водный баланс</kwd><kwd>биоимпеданс</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hemodialysis</kwd><kwd>adequacy</kwd><kwd>clinical guidelines</kwd><kwd>volume status</kwd><kwd>bioimpedance</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I. Impact of initial dialysis modality on mortality: a propensity-matched study. BMC Nephrol 2015;16:179. Doi: 10.1186/s12882-015-0175-5</mixed-citation><mixed-citation xml:lang="en">Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I. Impact of initial dialysis modality on mortality: a propensity-matched study. BMC Nephrol 2015;16:179. Doi: 10.1186/s12882-015-0175-5</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Jaar BG, Coresh J, Plantinga LC et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005;143(3):174–183</mixed-citation><mixed-citation xml:lang="en">Jaar BG, Coresh J, Plantinga LC et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005;143(3):174–183</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Han SS, Park JY, Kang S et al. Dialysis Modality and Mortality in the Elderly: A Meta-Analysis. Clin J Am Soc Nephrol 2015;10(6):983–993. Doi: 10.2215/CJN.05160514</mixed-citation><mixed-citation xml:lang="en">Han SS, Park JY, Kang S et al. Dialysis Modality and Mortality in the Elderly: A Meta-Analysis. Clin J Am Soc Nephrol 2015;10(6):983–993. Doi: 10.2215/CJN.05160514</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sim JJ, Zhou H, Shi J et al. Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters. Int Urol Nephrol 2018;50(5):963–971. Doi: 10.1007/s11255-018-1837-6.</mixed-citation><mixed-citation xml:lang="en">Sim JJ, Zhou H, Shi J et al. Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters. Int Urol Nephrol 2018;50(5):963–971. Doi: 10.1007/s11255-018-1837-6.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Li WY, Wang YC, Hwang SJ et al. Comparison of outcomes between emergent-start and planned-start peritoneal dialysis in incident ESRD patients: a prospective observational study. BMC Nephrol 2017;18(1):359. Doi: 10.1186/s12882-017-0764-6.</mixed-citation><mixed-citation xml:lang="en">Li WY, Wang YC, Hwang SJ et al. Comparison of outcomes between emergent-start and planned-start peritoneal dialysis in incident ESRD patients: a prospective observational study. BMC Nephrol 2017;18(1):359. Doi: 10.1186/s12882-017-0764-6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Phirtskhalaishvili T, Bayer F, Edet S et al. Spatial Analysis of Case-Mix and Dialysis Modality Associations. Perit Dial Int 2016;36(3):326–333. Doi: 10.3747/pdi.2015.00003</mixed-citation><mixed-citation xml:lang="en">Phirtskhalaishvili T, Bayer F, Edet S et al. Spatial Analysis of Case-Mix and Dialysis Modality Associations. Perit Dial Int 2016;36(3):326–333. Doi: 10.3747/pdi.2015.00003</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C. The Rise of Expanded Hemodialysis. Blood Purif 2017;44(2):I–VIII. Doi: 10.1159/000476012</mixed-citation><mixed-citation xml:lang="en">Ronco C. The Rise of Expanded Hemodialysis. Blood Purif 2017;44(2):I–VIII. Doi: 10.1159/000476012</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Florens N, Juillard L. Expanded haemodialysis: news from the field. Nephrol Dial Transplant 2018 Oct 1;33(suppl_3):iii48– iii52. Doi: 10.1093/ndt/gfy203</mixed-citation><mixed-citation xml:lang="en">Florens N, Juillard L. Expanded haemodialysis: news from the field. Nephrol Dial Transplant 2018 Oct 1;33(suppl_3):iii48– iii52. Doi: 10.1093/ndt/gfy203</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Андрусев АМ, Земченков АЮ. Режим диализа и остаточная функция почек. Нефрология и диализ 2017;19(4): 522–530 [Andrusev AM, Zemchenkov AY. Dialysis schedule and residual renal function. Nephrology and Dialysis (in Russ) 2017;19(4): 522–530. Doi: 10.28996/1680-4422-2017-4-522-530]</mixed-citation><mixed-citation xml:lang="en">Andrusev AM, Zemchenkov AY. Dialysis schedule and residual renal function. Nephrology and Dialysis (in Russ) 2017;19(4): 522–530. Doi: 10.28996/1680-4422-2017-4-522-530</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rhee CM, Ghahremani-Ghajar M, Obi Y, Kalantar-Zadeh K. Incremental and infrequent hemodialysis: a new paradigm for both dialysis initiation and conservative management. Panminerva Med 2017; 59(2): 188–196. Doi: 10.23736/S0031-0808.17.03299-2</mixed-citation><mixed-citation xml:lang="en">Rhee CM, Ghahremani-Ghajar M, Obi Y, Kalantar-Zadeh K. Incremental and infrequent hemodialysis: a new paradigm for both dialysis initiation and conservative management. Panminerva Med 2017; 59(2): 188–196. Doi: 10.23736/S0031-0808.17.03299-2</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Obi Y, Streja E, Rhee CM et al. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study. Am J Kidney Dis 2016;68(2):256–265. Doi: 10.1053/j.ajkd.2016.01.008</mixed-citation><mixed-citation xml:lang="en">Obi Y, Streja E, Rhee CM et al. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study. Am J Kidney Dis 2016;68(2):256–265. Doi: 10.1053/j.ajkd.2016.01.008</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Morfín JA, Yang A, Wang E, Schiller B. Transitional dialysis care units: A new approach to increase home dialysis modality uptake and patient outcomes. Semin Dial 2018;31(1):82–87. Doi: 10.1111/sdi.12651</mixed-citation><mixed-citation xml:lang="en">Morfín JA, Yang A, Wang E, Schiller B. Transitional dialysis care units: A new approach to increase home dialysis modality uptake and patient outcomes. Semin Dial 2018;31(1):82–87. Doi: 10.1111/sdi.12651</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Segall L, Nistor I, Van Biesen W et al. Dialysis modality choice in elderly patients with end-stage renal disease: a narrative review of the available evidence. Nephrol Dial Transplant 2017;32(1):41–49. Doi: 10.1093/ndt/gfv411</mixed-citation><mixed-citation xml:lang="en">Segall L, Nistor I, Van Biesen W et al. Dialysis modality choice in elderly patients with end-stage renal disease: a narrative review of the available evidence. Nephrol Dial Transplant 2017;32(1):41–49. Doi: 10.1093/ndt/gfv411</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Purnell TS, Auguste P, Crews DC et al. Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis 2013;62(5):953–973. Doi: 10.1053/j. ajkd.2013.03.022</mixed-citation><mixed-citation xml:lang="en">Purnell TS, Auguste P, Crews DC et al. Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis 2013;62(5):953–973. Doi: 10.1053/j. ajkd.2013.03.022</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ, Сапон НГ, Костылева ТГ и др. Оценка качества жизни у пациентов на гемо- и перитонеальном диализе с помощью опросника KDQOL-SF™. Нефрология и диализ 2009;11(2):94–102</mixed-citation><mixed-citation xml:lang="en">Zemchenkov AYu, Sapon NG, Kostyleva TG et al. Assessment of quality of life in patients on hemodialysis and peritoneal dialysis by questionnaire KDQOL-SF™. Nephrology and Dialysis 2009;11(2):94–102</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Finderup J, Jensen JKD, Lomborg K. Developing and pilot testing a shared decision-making intervention for dialysis choice. J Ren Care 2018 Apr 17. Doi: 10.1111/jorc.12241 [Epub ahead of print]</mixed-citation><mixed-citation xml:lang="en">Finderup J, Jensen JKD, Lomborg K. Developing and pilot testing a shared decision-making intervention for dialysis choice. J Ren Care 2018 Apr 17. Doi: 10.1111/jorc.12241 [Epub ahead of print]</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zee J, Zhao J, Subramanian L et al. Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients. BMC Nephrol 2018;19(1):298. Doi: 10.1186/s12882-018-1096-x</mixed-citation><mixed-citation xml:lang="en">Zee J, Zhao J, Subramanian L et al. Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients. BMC Nephrol 2018;19(1):298. Doi: 10.1186/s12882-018-1096-x</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Couchoud C, Bolignano D, Nistor I et al. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. Nephrol Dial Transplant 2015; 30(2):310–320. Doi: 10.1093/ndt/gfu293</mixed-citation><mixed-citation xml:lang="en">Couchoud C, Bolignano D, Nistor I et al. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. Nephrol Dial Transplant 2015; 30(2):310–320. Doi: 10.1093/ndt/gfu293</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lee MJ, Kwon YE, Park KS et al. Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea. Medicine (Baltimore) 2016;95(11):e3118. Doi: 10.1097/MD.0000000000003118</mixed-citation><mixed-citation xml:lang="en">Lee MJ, Kwon YE, Park KS et al. Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea. Medicine (Baltimore) 2016;95(11):e3118. Doi: 10.1097/MD.0000000000003118</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Legendre C, Canaud G, Martinez F. Factors influencing long-term outcome after kidney transplantation. Transpl Int 2014;27:19–27.Doi:10.1111/tri.12217</mixed-citation><mixed-citation xml:lang="en">Legendre C, Canaud G, Martinez F. Factors influencing long-term outcome after kidney transplantation. Transpl Int 2014;27:19–27.Doi:10.1111/tri.12217</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Wu DA, Robb ML, Watson CJE et al. Barriers to living donor kidney transplantation in the United Kingdom: a national observational study. Nephrol Dial Transplant 2017;32(5):890–900. Doi:10.1093/ndt/gfx036</mixed-citation><mixed-citation xml:lang="en">Wu DA, Robb ML, Watson CJE et al. Barriers to living donor kidney transplantation in the United Kingdom: a national observational study. Nephrol Dial Transplant 2017;32(5):890–900. Doi:10.1093/ndt/gfx036</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">López-Oliva MO, Rivas B, Pérez-Fernández E et al. Pretransplant peritoneal dialysis relative to hemodialysis improves long-term survival of kidney transplant patients: a single-center observational study. Int Urol Nephrol 2014;46(4):825–832. Doi:10.1007/s11255-013-0521-0</mixed-citation><mixed-citation xml:lang="en">López-Oliva MO, Rivas B, Pérez-Fernández E et al. Pretransplant peritoneal dialysis relative to hemodialysis improves long-term survival of kidney transplant patients: a single-center observational study. Int Urol Nephrol 2014;46(4):825–832. Doi:10.1007/s11255-013-0521-0</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tang M, Li T, Liu H. A comparison of transplant outcomes in peritoneal and hemodialysis patients: a meta-analysis. Blood Purif 2016;42(2):170–176.Doi:10.1159/000446272</mixed-citation><mixed-citation xml:lang="en">Tang M, Li T, Liu H. A comparison of transplant outcomes in peritoneal and hemodialysis patients: a meta-analysis. Blood Purif 2016;42(2):170–176.Doi:10.1159/000446272</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lin HT, Liu FC, Lin JR et al. Impact of the pretransplant dialysis modality on kidney transplantation outcomes: a nationwide cohort study. BMJ Open 2018 Jun 4;8(6):e020558. Doi: 10.1136/ bmjopen-2017-020558</mixed-citation><mixed-citation xml:lang="en">Lin HT, Liu FC, Lin JR et al. Impact of the pretransplant dialysis modality on kidney transplantation outcomes: a nationwide cohort study. BMJ Open 2018 Jun 4;8(6):e020558. Doi: 10.1136/ bmjopen-2017-020558</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">de Fijter CWH, van Diepen ATN, Amiri F et al. Patientreported outcomes (PROs) argue against the limited use of peritoneal dialysis in end-stage renal disease. Clin Nephrol 2018; 90(2):94–101. Doi: 10.5414/CN109369</mixed-citation><mixed-citation xml:lang="en">de Fijter CWH, van Diepen ATN, Amiri F et al. Patientreported outcomes (PROs) argue against the limited use of peritoneal dialysis in end-stage renal disease. Clin Nephrol 2018; 90(2):94–101. Doi: 10.5414/CN109369</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Trinh E, Chan CT, Perl J et al. Dialysis modality and survival: Done to death. Semin Dial 2018;31(4):315–324. Doi: 10.1111/ sdi.12692</mixed-citation><mixed-citation xml:lang="en">Trinh E, Chan CT, Perl J et al. Dialysis modality and survival: Done to death. Semin Dial 2018;31(4):315–324. Doi: 10.1111/ sdi.12692</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Томилина НА, Андрусев АМ, Перегудова НГ и др. Заместительная терапия терминальной хронической почечной недостаточности в Российской Федерации в 2010–2015 гг. Часть первая. Нефрология и диализ 2017;19(4 – Приложение): 1–95. Doi: 10.28996/1680-4422-2017-4suppl-1-95</mixed-citation><mixed-citation xml:lang="en">Tomilina NA, Andrusev AM, Peregudova NG et al. Renal replacement therapy for End Stage Renal Disease in Russian Federation, 2010–2015. Part 1. Nephrology and Dialysis 2017;19(4-Suppl):1–95</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Heaf J, Petersons A, Vernere B et al. Why do physicians prescribe dialysis? A prospective questionnaire study. PLoS One 2017;12(12):e0188309. Doi: 10.1371/journal.pone.0188309</mixed-citation><mixed-citation xml:lang="en">Heaf J, Petersons A, Vernere B et al. Why do physicians prescribe dialysis? A prospective questionnaire study. PLoS One 2017;12(12):e0188309. Doi: 10.1371/journal.pone.0188309</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K, Kovesdy CP, Streja E et al. Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Transplant 2017;32(suppl_2):ii91–ii98. Doi: 10.1093/ndt/gfw357</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K, Kovesdy CP, Streja E et al. Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Transplant 2017;32(suppl_2):ii91–ii98. Doi: 10.1093/ndt/gfw357</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ, Вишневский КА, Сабодаш АБ и др. Сроки начала и другие факторы на старте диализа, влияющие на выживаемость: Санкт-Петербургский регистр пациентов на заместительной почечной терапии. Нефрология и диализ 2017;19(2): 255–270. Doi: 10.28996/1680-4422-2017-2-255-270.</mixed-citation><mixed-citation xml:lang="en">Zemchenkov A, Vishnevskii KA, Sabodash AB et al. The timing and other dialysis start features associated with survival: St-Petersburg renal replacement therapy register. Nephrology and Dialysis 2017;19(2): 255–270</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ, Андрусев АМ, Виталюева МА. Заместительная почечная терапия в новых нормативных документах на 2017. Нефрология и диализ 2016;18(4):362–373</mixed-citation><mixed-citation xml:lang="en">Zemchenkov AYu, Andrusev АМ, Vitaliueva МА. Renal replacement therapy in new legislative conditions for 2017. Nephrology and Dialysis 2016;18(4):362–373</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Osman MA, Alrukhaimi M, Ashuntantang GE et al. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney International Supplements 2018; 8(2):52–63. Doi:10.1016/j.kisu.2017.10.009</mixed-citation><mixed-citation xml:lang="en">Osman MA, Alrukhaimi M, Ashuntantang GE et al. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney International Supplements 2018; 8(2):52–63. Doi:10.1016/j.kisu.2017.10.009</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Maddux DW, Usvyat LA, Ketchersid T et al. Clinical parameters before and after the transition to dialysis. Hemodial Int 2018;22(2):235–244. Doi: 10.1111/hdi.12603</mixed-citation><mixed-citation xml:lang="en">Maddux DW, Usvyat LA, Ketchersid T et al. Clinical parameters before and after the transition to dialysis. Hemodial Int 2018;22(2):235–244. Doi: 10.1111/hdi.12603</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Rhee CM, Kovesdy CP, Ravel VA et al. Association of Glycemic Status During Progression of CKD With Early Dialysis Mortality in Patients With Diabetes. Diabetes Care 2017;40(8):1050–1057. Doi: 10.2337/dc17-0110</mixed-citation><mixed-citation xml:lang="en">Rhee CM, Kovesdy CP, Ravel VA et al. Association of Glycemic Status During Progression of CKD With Early Dialysis Mortality in Patients With Diabetes. Diabetes Care 2017;40(8):1050–1057. Doi: 10.2337/dc17-0110</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Sumida K, Diskin CD, Molnar MZ et al. Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis. Am J Nephrol 2017;46(5):397–407. Doi: 10.1159/000484356</mixed-citation><mixed-citation xml:lang="en">Sumida K, Diskin CD, Molnar MZ et al. Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis. Am J Nephrol 2017;46(5):397–407. Doi: 10.1159/000484356</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Sumida K, Molnar MZ, Potukuchi PK et al. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol Dial Transplant 2018;33(2):264–273. Doi: 10.1093/ndt/gfw412</mixed-citation><mixed-citation xml:lang="en">Sumida K, Molnar MZ, Potukuchi PK et al. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrol Dial Transplant 2018;33(2):264–273. Doi: 10.1093/ndt/gfw412</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Sumida K, Molnar MZ, Potukuchi PK et al. Blood Pressure Before Initiation of Maintenance Dialysis and Subsequent Mortality. Am J Kidney Dis 2017;70(2):207–217. Doi: 10.1053/j. ajkd.2016.12.020</mixed-citation><mixed-citation xml:lang="en">Sumida K, Molnar MZ, Potukuchi PK et al. Blood Pressure Before Initiation of Maintenance Dialysis and Subsequent Mortality. Am J Kidney Dis 2017;70(2):207–217. Doi: 10.1053/j. ajkd.2016.12.020</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Arif FM, Sumida K, Molnar MZ et al. Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease. Nephron 2017;137(1):15–22. Doi: 10.1159/000473704</mixed-citation><mixed-citation xml:lang="en">Arif FM, Sumida K, Molnar MZ et al. Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease. Nephron 2017;137(1):15–22. Doi: 10.1159/000473704</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Molnar MZ, Streja E, Sumida K et al. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis. Clin J Am Soc Nephrol 2017;12(9):1428–1437. Doi: 10.2215/CJN.00570117</mixed-citation><mixed-citation xml:lang="en">Molnar MZ, Streja E, Sumida K et al. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis. Clin J Am Soc Nephrol 2017;12(9):1428–1437. Doi: 10.2215/CJN.00570117</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Sumida K, Molnar MZ, Potukuchi PK. Pre-end-stage renal disease visit-to-visit systolic blood pressure variability and post-end-stage renal disease mortality in incident dialysis patients. J Hypertens 2017;35(9):1816–1824. Doi: 10.1097/ HJH.0000000000001376</mixed-citation><mixed-citation xml:lang="en">Sumida K, Molnar MZ, Potukuchi PK. Pre-end-stage renal disease visit-to-visit systolic blood pressure variability and post-end-stage renal disease mortality in incident dialysis patients. J Hypertens 2017;35(9):1816–1824. Doi: 10.1097/ HJH.0000000000001376</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Ramspek CL, Voskamp PWM, Krediet RT et al. Prediction models for the mortality risk in chronic dialysis patients: a systematic review and independent external validation study. Nephrol Dial Transplant 2016; 31 (suppl_1): i20. Doi: 10.1093/ndt/gfw125.01</mixed-citation><mixed-citation xml:lang="en">Ramspek CL, Voskamp PWM, Krediet RT et al. Prediction models for the mortality risk in chronic dialysis patients: a systematic review and independent external validation study. Nephrol Dial Transplant 2016; 31 (suppl_1): i20. Doi: 10.1093/ndt/gfw125.01</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ, Герасимчук РП, Сабодаш АБ и др. Определение сроков начала гемодиализа: разработка и подтверждение шкалы START. Вестник трансплантологии и искусственных органов 2018;20(2):47–60</mixed-citation><mixed-citation xml:lang="en">Zemchenkov AY, Gerasimchuk RP, Sabodash AB et al. Dialysis start timing: development and validation of START scoring scale. Russian Journal of Transplantology and Artificial Organs 2018;20(2):47–60 (In Russ.). Doi.org/10.15825/1995-1191-2018-2-47-60</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Floege J, Gillespie IA, Kronenberg F et al. Development and validation of a predictive mortality risk score from a European hemodialysis cohort. Kidney Int 2015; 87 (5): 996–1008. Doi: 10.1038/ki.2014.419</mixed-citation><mixed-citation xml:lang="en">Floege J, Gillespie IA, Kronenberg F et al. Development and validation of a predictive mortality risk score from a European hemodialysis cohort. Kidney Int 2015; 87 (5): 996–1008. Doi: 10.1038/ki.2014.419</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010;363(7):609–619. Doi: 10.1056/NEJMoa1000552</mixed-citation><mixed-citation xml:lang="en">Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010;363(7):609–619. Doi: 10.1056/NEJMoa1000552</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Tangri N, Grams ME, Levey AS et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA 2016;315(2):164–174. Doi: 10.1001/ jama.2015.18202</mixed-citation><mixed-citation xml:lang="en">Tangri N, Grams ME, Levey AS et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA 2016;315(2):164–174. Doi: 10.1001/ jama.2015.18202</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Tangri N, Stevens LA, Griffith J et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011;305(15):1553–1559. Doi: 10.1001/jama.2011.451</mixed-citation><mixed-citation xml:lang="en">Tangri N, Stevens LA, Griffith J et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011;305(15):1553–1559. Doi: 10.1001/jama.2011.451</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ. Использование балльных шкал, предложенных в Клинических рекомендациях European Renal Best Practice для оценки прогноза у пожилых и ослабленных пациентов на поздних стадиях ХБП. Нефрология и диализ 2017;19(1):221–225</mixed-citation><mixed-citation xml:lang="en">Zemchenkov AYu. The use of scores suggested by European Renal Best Practice for prognosis evaluation for frail patients with CKD 3B and higher. Nephrology and Dialysis (in Russ) 2017;19(1):221–225</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Bylsma LC, Gage SM, Reichert H et al. Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes. Eur J Vasc Endovasc Surg 2017;54(4):513–522. Doi: 10.1016/j.ejvs.2017.06.024. Epub 2017 Aug 23</mixed-citation><mixed-citation xml:lang="en">Bylsma LC, Gage SM, Reichert H et al. Arteriovenous Fistulae for Haemodialysis: A Systematic Review and Meta-analysis of Efficacy and Safety Outcomes. Eur J Vasc Endovasc Surg 2017;54(4):513–522. Doi: 10.1016/j.ejvs.2017.06.024. Epub 2017 Aug 23</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Ватазин АВ, Зулькарнаев АБ, Фоминых НМ и др. Сосудистый доступ у пациентов на хроническом гемодиализе в Московской области: состояние и перспективы. Альманах клинической медицины 2017;45(7):526–534</mixed-citation><mixed-citation xml:lang="en">Vatazin AV, Zulkarnaev AB, Fominykh NM et al. Vascular access in patients on chronic hemodialysis in the Moscow Region: current state and outlook. Almanac of Clinical Medicine. 2017;45(7):526–534. Doi: 10.18786/2072-0505-2017-45-7-526-534</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Ravani P, Quinn R, Oliver M et al. Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications. Clin J Am Soc Nephrol 2017;12(6):955–964. Doi: 10.2215/CJN.12181116</mixed-citation><mixed-citation xml:lang="en">Ravani P, Quinn R, Oliver M et al. Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications. Clin J Am Soc Nephrol 2017;12(6):955–964. Doi: 10.2215/CJN.12181116</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Antlanger M, Aschauer S, Kopecky C et al. Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis. Kidney Blood Press Res 2017;42(1):165–176. Doi: 10.1159/000473868</mixed-citation><mixed-citation xml:lang="en">Zeltyn-Abramov EM, Kotenko ON, Andrusev AM et al. High-output heart failure in a hemodialysis patient (Case Study and Short Review). Nephrology and Dialysis 2016;18(3):319–327 (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Зелтынь-Абрамов ЕМ, Котенко ОН, Андрусев АМ и др. Сердечная недостаточность с высоким сердечным выбросом у пациентки на программном гемодиализе (Наблюдение из практики и краткий обзор литературы). Нефрология и диализ 2016;18(3):319–327</mixed-citation><mixed-citation xml:lang="en">Sumida K, Molnar MZ, Potukuchi PK et al. Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease. Nephrol Dial Transplant 2017;32(8):1330–1337. Doi: 10.1093/ndt/gfw220</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Sumida K, Molnar MZ, Potukuchi PK et al. Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease. Nephrol Dial Transplant 2017;32(8):1330–1337. Doi: 10.1093/ndt/gfw220</mixed-citation><mixed-citation xml:lang="en">Janmaat CJ, van Diepen M, van Hagen CC. Decline of kidney function during the pre-dialysis period in chronic kidney disease patients: a systematic review and meta-analysis. Clin Epidemiol 2018;10:613–622. Doi: 10.2147/CLEP.S153367</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Janmaat CJ, van Diepen M, van Hagen CC. Decline of kidney function during the pre-dialysis period in chronic kidney disease patients: a systematic review and meta-analysis. Clin Epidemiol 2018;10:613–622. Doi: 10.2147/CLEP.S153367</mixed-citation><mixed-citation xml:lang="en">Zemchenkov AYu, Konakova IN. The chronic kidney disease progression rates according to St.-Petersburg CKD register. Nephrology and Dialysis 2015;17(1):34–51 (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ, Конакова ИН. Темпы прогрессирования хронической болезни почек по данным Санкт-Петербургского городского регистра ХБП. Нефрология и диализ 2015;17(1):34–51</mixed-citation><mixed-citation xml:lang="en">O'Hare AM, Bertenthal D, Walter LC et al. When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007;71(6):555–561</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">O'Hare AM, Bertenthal D, Walter LC et al. When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007;71(6):555–561</mixed-citation><mixed-citation xml:lang="en">Zemchenkov A, Konakova I, Sabodash A et al. Three-year predialysis trajectories of eGFR decline before dialysis according to city CKD register data. Clinical Nephrology 2017;(2):4–11</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ, Конакова ИН, Сабодаш АБ и соавт. Трехлетние траектории снижения расчетной СКФ перед началом диализа по данным городского регистра пациентов с ХБП. Клиническая нефрология 2017; (2):4–11</mixed-citation><mixed-citation xml:lang="en">Evangelidis N, Tong A, Manns B et al. Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Initiative. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. Am J Kidney Dis 2017;70(4):464–475. Doi: 10.1053/j.ajkd.2016.11.029</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Evangelidis N, Tong A, Manns B et al. Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Initiative. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey. Am J Kidney Dis 2017;70(4):464–475. Doi: 10.1053/j.ajkd.2016.11.029</mixed-citation><mixed-citation xml:lang="en">Johnson R, Feehally J, Floege J. Comprehensive Clinical Nephrology, 5th Edition; eBook ISBN: 9780323242875. Saunders; 2014 – 1320 p</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson R, Feehally J, Floege J. Comprehensive Clinical Nephrology, 5th Edition; eBook ISBN: 9780323242875. Saunders; 2014 – 1320 p</mixed-citation><mixed-citation xml:lang="en">Zemchenkov GA, Sabodash AB, Kazantseva NS et al. Classic and on line methods for Kt/V measurement: comparison and reliability. Nephrology and Dialysis 2015;17(2):173–184 (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков ГА, Сабодаш АБ, Казанцева НС и др. Классические и online методы измерения KT/V: сопоставления и надежность. Нефрология и диализ 2015; 17(2):173–184</mixed-citation><mixed-citation xml:lang="en">Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4(5):1205–1213</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4(5):1205–1213</mixed-citation><mixed-citation xml:lang="en">Daugirdas JD, Blake PB, Todd S. Ing T.S. Handbook of Dialysis, 5th Edition. - LWW/-2014: 900</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Daugirdas JD, Blake PB, Todd S. Ing T.S. Handbook of Dialysis, 5th Edition. - LWW/-2014: 900</mixed-citation><mixed-citation xml:lang="en">Daugirdas JT, Depner TA Gotch FA et al. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 1997;52(5):1395–1405</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Daugirdas JT, Depner TA Gotch FA et al. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 1997;52(5):1395–1405</mixed-citation><mixed-citation xml:lang="en">Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose (delta Kt/V) depends on dialysis efficiency (K/V) by regional blood flow and conventional 2-pool urea kinetic analyses. ASAJO J 1995; 41:M719–M724</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose (delta Kt/V) depends on dialysis efficiency (K/V) by regional blood flow and conventional 2-pool urea kinetic analyses. ASAJO J 1995; 41:M719–M724</mixed-citation><mixed-citation xml:lang="en">Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. Hemodialysis (HEMO) Study Group. N Engl J Med 2002;347(25):2010–2009</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. Hemodialysis (HEMO) Study Group. N Engl J Med 2002;347(25):2010–2009</mixed-citation><mixed-citation xml:lang="en">Zemchenkov AYu, Gerasimchuk RP, Sabodash AB. Hemodiafiltration: attention on the volume. Review. Nephrology and Dialysis 2014;16(1):128–138 (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ, Герасимчук РП, Сабодаш АБ. Гемодиафильтрация: внимание на объем (обзор литературы). Нефрология и диализ 2014; 16(1):128–138</mixed-citation><mixed-citation xml:lang="en">Peters SA, Bots ML, Canaud B et al. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant 2016;31(6):978–984. Doi: 10.1093/ ndt/gfv349</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Peters SA, Bots ML, Canaud B et al. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant 2016;31(6):978–984. Doi: 10.1093/ ndt/gfv349</mixed-citation><mixed-citation xml:lang="en">Strokov GA, Gurevich KYa, Ilyin AP et al. Treatment of patients with chronic kidney disease stage 5 (CKD 5) by hemodialysis and hemodiafiltration. Clinical guidelines. Nephrology 2017;21(3):92–111. Doi: 10.24884/1561-6274-2017-3-92-111 (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Строков АГ, Гуревич КЯ, Ильин АП и соавт. Лечение пациентов с хронической болезнью почек 5 стадии (ХБП 5) методами гемодиализа и гемодиафильтрации. Клинические рекомендации. Нефрология 2017; 21(3):92–111</mixed-citation><mixed-citation xml:lang="en">Daugirdas JT, Depner TA, Inrig J et al. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. National Kidney Foundation. Am J Kidney Dis 2015;66(5):884–930. Doi: 10.1053/j.ajkd.2015.07.015</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Daugirdas JT, Depner TA, Inrig J et al. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. National Kidney Foundation. Am J Kidney Dis 2015;66(5):884–930. Doi: 10.1053/j.ajkd.2015.07.015</mixed-citation><mixed-citation xml:lang="en">Jindal K, Chan CT, Deziel C et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. Canadian Society of Nephrology Committee for Clinical Practice Guidelines. J Am Soc Nephrol 2006;17(3 Suppl 1):S1–27. Doi: 10.1681/ASN.2005121372</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Jindal K, Chan CT, Deziel C et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. Canadian Society of Nephrology Committee for Clinical Practice Guidelines. J Am Soc Nephrol 2006;17(3 Suppl 1):S1–27. Doi: 10.1681/ASN.2005121372</mixed-citation><mixed-citation xml:lang="en">Nesrallah GE, Mustafa RA, MacRae J et al. Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis. Am J Kidney Dis 2013;62(1):187–198. Doi: 10.1053/j.ajkd.2013.02.351</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Nesrallah GE, Mustafa RA, MacRae J et al. Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis. Am J Kidney Dis 2013;62(1):187–198. Doi: 10.1053/j.ajkd.2013.02.351</mixed-citation><mixed-citation xml:lang="en">European Best Practice Guidelines for Haemodialysis (Part 1). II.1 Haemodialysis dose quantification: small solutes. Nephrology Dialysis Transplantation 2002; 17(suppl_7):17–21. Doi: 10.1093/ndt/17.suppl_7.17</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">European Best Practice Guidelines for Haemodialysis (Part 1). II.1 Haemodialysis dose quantification: small solutes. Nephrology Dialysis Transplantation 2002; 17(suppl_7):17–21. Doi: 10.1093/ndt/17.suppl_7.17</mixed-citation><mixed-citation xml:lang="en">Mactier R, Hoenich N, Breen C. Renal Association Clinical Practice Guideline on haemodialysis. Nephron Clin Pract 2011;118 Suppl 1:c241–86. Doi: 10.1159/000328072</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Mactier R, Hoenich N, Breen C. Renal Association Clinical Practice Guideline on haemodialysis. Nephron Clin Pract 2011;118 Suppl 1:c241–86. Doi: 10.1159/000328072</mixed-citation><mixed-citation xml:lang="en">Bikbov BT, Tomilina NA. The contingent and treatment quality indicators in patients on replacement therapy of end stage renal disease in the Russian Federation in 1998-2013 years. Nephrology and Dialysis 2016;18(2): 98–164 (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Бикбов БТ, Томилина НА. Состав больных и показатели качества лечения на заместительной терапии терминальной хронической почечной недостаточности в Российской Федерации в 1998-2013 гг. Нефрология и Диализ 2016;18(2):98–164</mixed-citation><mixed-citation xml:lang="en">Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998;13 Suppl 6:10–14</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998;13 Suppl 6:10–14</mixed-citation><mixed-citation xml:lang="en">Leypoldt JK, Jaber BL, Zimmerman DL. Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial 2004;17(2):142–145</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Leypoldt JK, Jaber BL, Zimmerman DL. Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial 2004;17(2):142–145</mixed-citation><mixed-citation xml:lang="en">Daugirdas JT, Depner TA, Greene T et al. Standard Kt/ Vurea: A method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int 2010;77(7):637–644. Doi: 10.1038/ki.2009.525</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Daugirdas JT, Depner TA, Greene T et al. Standard Kt/ Vurea: A method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int 2010;77(7):637–644. Doi: 10.1038/ki.2009.525</mixed-citation><mixed-citation xml:lang="en">Rivara MB, Ravel V, Streja E et al. Weekly Standard Kt/ Vurea and Clinical Outcomes in Home and In-Center Hemodialysis. Clin J Am Soc Nephrol 2018;13(3):445–455. Doi: 10.2215/ CJN.05680517</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Rivara MB, Ravel V, Streja E et al. Weekly Standard Kt/ Vurea and Clinical Outcomes in Home and In-Center Hemodialysis. Clin J Am Soc Nephrol 2018;13(3):445–455. Doi: 10.2215/ CJN.05680517</mixed-citation><mixed-citation xml:lang="en">Schneditz D, Daugirdas JT. Compartment effects in hemodialysis. Semin Dial 2001;14(4):271–277</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Schneditz D, Daugirdas JT. Compartment effects in hemodialysis. Semin Dial 2001;14(4):271–277</mixed-citation><mixed-citation xml:lang="en">Debowska M, Poleszczuk J, Wojcik-Zaluska A et al. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling. Artif Organs 2015;39(12):1005–1014. Doi: 10.1111/aor.12489</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Debowska M, Poleszczuk J, Wojcik-Zaluska A et al. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling. Artif Organs 2015;39(12):1005–1014. Doi: 10.1111/aor.12489</mixed-citation><mixed-citation xml:lang="en">Vasilevsky AM, Gerasimchuk RP, Zemchenkov AYu et al. Dual-Wavelength Optoelectronic Sensor for Monitoring Uric Acid Concentration in Dialysate. Biomedical Engineering 2015;49(3):125–128. Translated from Meditsinskaya Tekhnika 2015;49(3):1–3 Doi: 10.1007/s10527-015-9512-z</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Василевский АМ, Герасимчук РП, Земченков АЮ и др. Двухволновой оптико-электронный сенсор для мониторинга концентрации мочевой кислоты в диализной жидкости. Медицинская техника 2015;3:1–3</mixed-citation><mixed-citation xml:lang="en">Thompson S, Manns B, Lloyd A et al. Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial. Nephrol Dial Transplant 2017;32(5):855–861. Doi: 10.1093/ndt/gfw085</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Thompson S, Manns B, Lloyd A et al. Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial. Nephrol Dial Transplant 2017;32(5):855–861. Doi: 10.1093/ndt/gfw085</mixed-citation><mixed-citation xml:lang="en">Meyer TW, Sirich TL, Hostetter TH. Dialysis cannot be dosed. Semin Dial 2011;24(5):471–479. Doi: 10.1111/j.1525-139X.2011.00979.x</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Meyer TW, Sirich TL, Hostetter TH. Dialysis cannot be dosed. Semin Dial 2011;24(5):471–479. Doi: 10.1111/j.1525-139X.2011.00979.x</mixed-citation><mixed-citation xml:lang="en">McIntyre CW, Harrison LE, Eldehni MT et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011;6(1):133–141. Doi: 10.2215/CJN.04610510</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">McIntyre CW, Harrison LE, Eldehni MT et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011;6(1):133–141. Doi: 10.2215/CJN.04610510</mixed-citation><mixed-citation xml:lang="en">Movilli E, Gaggia P, Zubani R et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007;22(12):3547–3552</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Movilli E, Gaggia P, Zubani R et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 2007;22(12):3547–3552</mixed-citation><mixed-citation xml:lang="en">Saran R, Bragg-Gresham JL, Levin NW et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006;69(7):1222–1228</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Saran R, Bragg-Gresham JL, Levin NW et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006;69(7):1222–1228</mixed-citation><mixed-citation xml:lang="en">Assimon MM, Wenger JB, Wang L, Flythe JE. Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients. Am J Kidney Dis 2016;68(6):911–922. Doi: 10.1053/j. ajkd.2016.06.020</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Assimon MM, Wenger JB, Wang L, Flythe JE. Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients. Am J Kidney Dis 2016;68(6):911–922. Doi: 10.1053/j. ajkd.2016.06.020</mixed-citation><mixed-citation xml:lang="en">Kim TW, Chang TI, Kim TH et al. Association of Ultrafiltration Rate with Mortality in Incident Hemodialysis Patients. Nephron 2018;139(1):13–22. Doi: 10.1159/000486323</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Kim TW, Chang TI, Kim TH et al. Association of Ultrafiltration Rate with Mortality in Incident Hemodialysis Patients. Nephron 2018;139(1):13–22. Doi: 10.1159/000486323</mixed-citation><mixed-citation xml:lang="en">Flythe JE, Assimon MM, Overman RA. Target weight achievement and ultrafiltration rate thresholds: potential patient implications. BMC Nephrol 2017;18(1):185. Doi: 10.1186/ s12882-017-0595-5</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Flythe JE, Assimon MM, Overman RA. Target weight achievement and ultrafiltration rate thresholds: potential patient implications. BMC Nephrol 2017;18(1):185. Doi: 10.1186/ s12882-017-0595-5</mixed-citation><mixed-citation xml:lang="en">Flythe JE, Kshirsagar AV, Falk RJ, Brunelli SM. Associations of posthemodialysis weights above and below target weight with all-cause and cardiovascular mortality. Clin J Am Soc Nephrol 2015;10(5):808–816. Doi: 10.2215/CJN.10201014</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Flythe JE, Kshirsagar AV, Falk RJ, Brunelli SM. Associations of posthemodialysis weights above and below target weight with all-cause and cardiovascular mortality. Clin J Am Soc Nephrol 2015;10(5):808–816. Doi: 10.2215/CJN.10201014</mixed-citation><mixed-citation xml:lang="en">Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int 2014;86(3):489–496. Doi: 10.1038/ki.2014.207</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int 2014;86(3):489–496. Doi: 10.1038/ki.2014.207</mixed-citation><mixed-citation xml:lang="en">Vishnevskii KA, Gerasimchuk RP, Zemchenkov AYu. «Dry weight» correction in hemodialysis patients based on the results of bioimpedance vector analysis. Nephrology 2014;18(2):61–71 (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Вишневский КА, Герасимчук РП, Земченков АЮ. Коррекция «сухого веса» у больных, получающих лечение программным гемодиализом по результатам векторного анализа биоимпеданса. Нефрология 2014;18(2):61–71</mixed-citation><mixed-citation xml:lang="en">Hecking M, Karaboyas A, Antlanger M et al. Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol 2013;38(1):78–90. Doi: 10.1159/000353104</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Hecking M, Karaboyas A, Antlanger M et al. Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol 2013;38(1):78–90. Doi: 10.1159/000353104</mixed-citation><mixed-citation xml:lang="en">Zoccali C, Moissl U, Chazot C et al. Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol 2017;28(8):2491– 2497. Doi: 10.1681/ASN.2016121341</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Zoccali C, Moissl U, Chazot C et al. Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol 2017;28(8):2491– 2497. Doi: 10.1681/ASN.2016121341</mixed-citation><mixed-citation xml:lang="en">Weiner DE, Brunelli SM, Hunt A et al. Improving clinical outcomes among hemodialysis patients: a proposal for a "volume first" approach from the chief medical officers of US dialysis providers. Am J Kidney Dis 2014;64(5):685–695. Doi: 10.1053/j. ajkd.2014.07.003</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Weiner DE, Brunelli SM, Hunt A et al. Improving clinical outcomes among hemodialysis patients: a proposal for a "volume first" approach from the chief medical officers of US dialysis providers. Am J Kidney Dis 2014;64(5):685–695. Doi: 10.1053/j. ajkd.2014.07.003</mixed-citation><mixed-citation xml:lang="en">Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009;4(12):1925–1931. Doi: 10.2215/CJN.04470709</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009;4(12):1925–1931. Doi: 10.2215/CJN.04470709</mixed-citation><mixed-citation xml:lang="en">McIntyre CW, Goldsmith DJ. Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension? Kidney Int 2015;87(6):1109–1115. Doi: 10.1038/ki.2015.62</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">McIntyre CW, Goldsmith DJ. Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension? Kidney Int 2015;87(6):1109–1115. Doi: 10.1038/ki.2015.62</mixed-citation><mixed-citation xml:lang="en">Perl J, Dember LM, Bargman JM et al. The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol 2017;12(5):839–847. Doi: 10.2215/CJN.08460816</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Perl J, Dember LM, Bargman JM et al. The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol 2017;12(5):839–847. Doi: 10.2215/CJN.08460816</mixed-citation><mixed-citation xml:lang="en">Hanafusa N, Tsuchiya K, Nitta K et al. Dialysate sodium concentration: The forgotten salt shaker. Semin Dial 2018;31(6):563–568. Doi: 10.1111/sdi.12749</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Hanafusa N, Tsuchiya K, Nitta K et al. Dialysate sodium concentration: The forgotten salt shaker. Semin Dial 2018;31(6):563–568. Doi: 10.1111/sdi.12749</mixed-citation><mixed-citation xml:lang="en">Jakovenko AA, Rumyantsev ASh. The prevalence of protein-energy wasting of haemodialysis patients. Nephrology and Dialysis 2019;21(1) (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Яковенко АА, Румянцев АШ. Распространенность белково-энергетической недостаточности у пациентов, получающих лечение программным гемодиализом. Нефрология и Диализ 2019;21(1)</mixed-citation><mixed-citation xml:lang="en">Piccoli GB, Nielsen L, Gendrot L et al. Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status. J Clin Med 2018;7(10). pii: E331. Doi: 10.3390/jcm7100331</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Piccoli GB, Nielsen L, Gendrot L et al. Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status. J Clin Med 2018;7(10). pii: E331. Doi: 10.3390/jcm7100331</mixed-citation><mixed-citation xml:lang="en">Sudden death and interval QTc in hemodialysis patients. Sabodash AB, Salikhova KA, Zemchenkov GA et al. Nephrology and Dialysis 2016;18(4):394–403 (in Russ)</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Сабодаш АБ, Салихова КА, Земченков ГА и др. Внезапная смерть и интервал QTc у пациентов на гемодиализе. Нефрология и диализ 2016;18(4):394–403</mixed-citation><mixed-citation xml:lang="en">Wetmore JB, Li S, Molony JT et al. Insights from the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients. Am J Kidney Dis 2018;71(1):123–132. Doi: 10.1053/j.ajkd.2017.08.023</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Wetmore JB, Li S, Molony JT et al. Insights from the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients. Am J Kidney Dis 2018;71(1):123–132. Doi: 10.1053/j.ajkd.2017.08.023</mixed-citation><mixed-citation xml:lang="en">Georgianos PI, Agarwal R. Blood pressure in hemodialysis: targets? Curr Opin Nephrol Hypertens 2017;26(6):523–529. Doi: 10.1097/MNH.0000000000000359</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Georgianos PI, Agarwal R. Blood pressure in hemodialysis: targets? Curr Opin Nephrol Hypertens 2017;26(6):523–529. Doi: 10.1097/MNH.0000000000000359</mixed-citation><mixed-citation xml:lang="en">Sabodash AB, Salikhova KA, Zemchenkov GA et al. Arterial hypertension and survival in hemodialysis patients. Nephrology and Dialysis (in Russ). 2016;18(4):416–430</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Сабодаш АБ, Салихова КА, Земченков ГА и др. Динамика артериальной гипертензии и выживаемость у пациентов на гемодиализе. Нефрология и диализ 2016; 18(4): 416–430</mixed-citation><mixed-citation xml:lang="en">Joki N, Tokumoto M, Takahashi N, Nishimura M. Current Perspectives on Sudden Cardiac Death in Hemodialysis Patients. Contrib Nephrol 2018;196:5–12. Doi: 10.1159/000485690</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Joki N, Tokumoto M, Takahashi N, Nishimura M. Current Perspectives on Sudden Cardiac Death in Hemodialysis Patients. Contrib Nephrol 2018;196:5–12. Doi: 10.1159/000485690</mixed-citation><mixed-citation xml:lang="en">Vázquez E, Sánchez-Perales C, García-García F et al. Sudden death in incident dialysis patients. Am J Nephrol 2014;39(4):331–336. Doi: 10.1159/000360547</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Vázquez E, Sánchez-Perales C, García-García F et al. Sudden death in incident dialysis patients. Am J Nephrol 2014;39(4):331–336. Doi: 10.1159/000360547</mixed-citation><mixed-citation xml:lang="en">Maduell F, Arias M, Durán CE et al. Nocturnal, everyother-day, online haemodiafiltration: an effective therapeutic alternative. Nephrol Dial Transplant 2012;27(4):1619–1631. Doi: 10.1093/ndt/gfr491</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Maduell F, Arias M, Durán CE et al. Nocturnal, everyother-day, online haemodiafiltration: an effective therapeutic alternative. Nephrol Dial Transplant 2012;27(4):1619–1631. Doi: 10.1093/ndt/gfr491</mixed-citation><mixed-citation xml:lang="en">Zemchenkov AYu, Gerasimchuk RP. The results of transfer to four times per week hemodialysis. Nephrology and Dialysis (in Russ). 2019; 21(1)</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Земченков АЮ, Герасимчук РП. Результаты перевода пациентов на четырехразовый гемодиализ. Нефрология и диализ 2019;21(1)</mixed-citation><mixed-citation xml:lang="en">Loutradis C, Sarafidis PA, Papadopoulos CE et al. The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD. J Am Soc Nephrol 2018;29(5):1372–1381. Doi: 10.1681/ ASN.2017101102</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Loutradis C, Sarafidis PA, Papadopoulos CE et al. The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD. J Am Soc Nephrol 2018;29(5):1372–1381. Doi: 10.1681/ ASN.2017101102</mixed-citation><mixed-citation xml:lang="en">Georgianos PI, Sarafidis PA. Pro: Should we move to more frequent haemodialysis schedules? Nephrol Dial Transplant 2015;30(1):18–22. Doi: 10.1093/ndt/gfu381</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Georgianos PI, Sarafidis PA. Pro: Should we move to more frequent haemodialysis schedules? Nephrol Dial Transplant 2015;30(1):18–22. Doi: 10.1093/ndt/gfu381</mixed-citation><mixed-citation xml:lang="en">Foley RN, Gilbertson DT, Murray T, Collins AJ. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011;365(12):1099–1107. Doi: 10.1056/NEJMoa1103313</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Foley RN, Gilbertson DT, Murray T, Collins AJ. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011;365(12):1099–1107. Doi: 10.1056/NEJMoa1103313</mixed-citation><mixed-citation xml:lang="en">Flythe JE, Dorough A, Narendra JH et al. Perspectives on symptom experiences and symptom reporting among individuals on hemodialysis. Nephrol Dial Transplant 2018;33(10):1842– 1852. Doi: 10.1093/ndt/gfy069</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Flythe JE, Dorough A, Narendra JH et al. Perspectives on symptom experiences and symptom reporting among individuals on hemodialysis. Nephrol Dial Transplant 2018;33(10):1842– 1852. Doi: 10.1093/ndt/gfy069</mixed-citation><mixed-citation xml:lang="en">Caskey F, Van Biesen W, Andreoli S et al. Integrated care for end stage kidney disease. The role of supportive care. Kidney International Supplements 2019; 9(2):</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Caskey F, Van Biesen W, Andreoli S et al. Integrated care for end stage kidney disease. The role of supportive care. Kidney International Supplements 2019; 9(2):</mixed-citation><mixed-citation xml:lang="en">Caskey F, Van Biesen W, Andreoli S et al. Integrated care for end stage kidney disease. The role of supportive care. Kidney International Supplements 2019; 9(2):</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
